Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

被引：24
|
作者：
de Zwaan, Sally E. [3 ]
Iland, Harry J. [1 ]
Damian, Diona L. [2 ,3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ Sydney, Dept Dermatol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 01期
关键词：
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate;
D O I：
10.1111/j.1440-0960.2008.00506.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
引用
收藏
页码：56 / 59
页数：4
相关论文
共 50 条
  • [41] Intravenous immunoglobulin is effective as a sole inummomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids
    Suchak, R
    Lawlor, F
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB241 - AB241
  • [42] Treatment of pyoderma gangrenosum
    Mekkes, Jan Robert
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [43] The treatment of choice for pyoderma gangrenosum complicating IBD - Intravenous cyclosporin.
    Friedman, S
    Marion, JF
    Scherl, E
    Rubin, P
    Present, DH
    GASTROENTEROLOGY, 1997, 112 (04) : A975 - A975
  • [44] IVIG Treatment for Refractory Pyoderma Gangrenosum in Patients with Inflammatory Bowel Disease
    Walters, Jamie
    Glover, Sarah
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S503 - S503
  • [45] Ustekinumab for Treatment of Refractory Pyoderma Gangrenosum in a Crohn's Disease Patient
    Groudan, Kevin
    Singhania, Rohit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1032 - S1032
  • [46] SUCCESSFUL TREATMENT OF ERUPTIVE PYODERMA-GANGRENOSUM WITH INTRAVENOUS VANCOMYCIN AND MEZLOCILLIN
    KANG, S
    DOVER, JS
    BRITISH JOURNAL OF DERMATOLOGY, 1990, 123 (03) : 389 - 393
  • [47] Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritis
    Cinotti, E.
    Labeille, B.
    Perrot, J. L.
    Pallot-Prades, B.
    Cambazard, F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (06) : 750 - 751
  • [48] The treatment of refractory uveitis with intravenous immunoglobulin
    Rosenbaum, JT
    George, RK
    Gordon, C
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 127 (05) : 545 - 549
  • [49] Pyoderma Gangrenosum-like Lesions in Leukocyte Adhesion Deficiency I Treated with Intravenous Immunoglobulin
    Nord, Kristin M.
    Pappert, Amy S.
    Grossman, Marc E.
    PEDIATRIC DERMATOLOGY, 2011, 28 (02) : 156 - 161
  • [50] A Case Report of a Patient with Crohn's Disease Complicated by Pyoderma Gangrenosum Treated with Intravenous Immunoglobulin
    Yoo, Lisa
    Elwir, Saleh
    Tinsley, Andrew
    Williams, Emmanuelle
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S421 - S421
12345